Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Haploinsufficiency of SHANK3 causes Phelan-McDermid syndrome and autism, whereas duplication of the same gene leads to SHANK3 duplication syndrome, a disorder characterized by neuropsychiatric phenotypes including hyperactivity and bipolar disorder as well as epilepsy.
|
30696942 |
2019 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Autism-associated Shank3 mutations alter mGluR expression and mGluR-dependent but not NMDA receptor-dependent long-term depression.
|
30868621 |
2019 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Altered spinogenesis in iPSC-derived cortical neurons from patients with autism carrying de novo SHANK3 mutations.
|
30643170 |
2019 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
To address this, we used mouse models of haploinsufficiency of the Shank3 gene (a highly penetrant monogenic autism risk factor), which exhibits prominent autism-like social deficits.
|
30659288 |
2019 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Collectively, our results reveal a critical role of SHANK3 in the development of prefrontal anatomy and function, and suggest that SHANK3 deficiency may predispose to intellectual disability and socio-communicative impairments via dysregulation of higher-order cortical connectivity.<b>SIGNIFICANCE STATEMENT</b> Mutations in the synaptic scaffolding protein SHANK3 are commonly associated with autism, intellectual, and language deficits.
|
31061091 |
2019 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Haploinsufficiency of Shank3, which encodes a scaffold protein at glutamatergic synapses, is causally linked to autism.
|
29760409 |
2018 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Shank3 mutation in a mouse model of autism leads to changes in the S-nitroso-proteome and affects key proteins involved in vesicle release and synaptic function.
|
29988084 |
2018 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We introduce findings in a rat model, and assess the impact of mutations in Shank3, an autism risk gene.
|
29377611 |
2018 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Considering that neurodevelopmental conditions, such as autism, have a strong genetic etiology, it is necessary to understand if genes associated with neurodevelopmental disorders, such as Shank3, can influence the gut microbiome, and if probiotics can be a therapeutic tool.
|
29787855 |
2018 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Publisher Correction: Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition.
|
29872123 |
2018 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
BEFREE |
Social deficits in Shank3-deficient mouse models of autism are rescued by histone deacetylase (HDAC) inhibition.
|
29531362 |
2018 |
Autistic Disorder
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Human SHANK3 mRNA shows developmentally regulated dendritic localization in hiPSC-derived neurons, which is reduced in neurons generated from a haploinsufficient individual with autism.
|
30064494 |
2018 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Two de novo novel mutations in one SHANK3 allele in a patient with autism and moderate intellectual disability.
|
29423971 |
2018 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we utilized the Shank3B mutant mouse model of autism to investigate how Shank3 mutation may differentially affect striatonigral (direct pathway) and striatopallidal (indirect pathway) medium spiny neurons (MSNs) and its relevance to repetitive grooming behavior in Shank3B mutant mice.
|
28414301 |
2017 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SHANK3 mutations are associated with autism, and patients with autism are known to have higher proportions of inflammatory bowel disease.
|
28906292 |
2017 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
These results demonstrate for the first time in this novel Shank3 mutant that both homozygous and heterozygous mutation of Shank3 lead to behavioral abnormalities with face validity for autism along with widespread synaptic dysfunction.Autism Res 2017, 10: 42-65.
|
27492494 |
2017 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SHANK3 mutations are responsible for Phelan-McDermid syndrome but they are also associated with autism and/or intellectual disability.
|
28754298 |
2017 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Zinc deficiency and low enterocyte zinc transporter expression in human patients with autism related mutations in SHANK3.
|
28345660 |
2017 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Human Pluripotent Stem Cell-derived Cortical Neurons for High Throughput Medication Screening in Autism: A Proof of Concept Study in SHANK3 Haploinsufficiency Syndrome.
|
27333044 |
2016 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our data suggest that SHANK3 mutations predispose to autism, at least partially, by inducing an Ih channelopathy that may be amenable to pharmacological intervention.
|
26966193 |
2016 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
With the recent report that SHANK3 mutations are present in approximately 2% of individuals with moderate to severe intellectual disabilities and 1% of individuals with autism, determining the spectrum of seizure semiologies and electrographic abnormalities will be critical for medical practitioners to appropriately counsel the families of patients with SHANK3 mutations.
|
27554343 |
2016 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we describe a complete knockout mouse model of the autism-associated Shank3 gene, with a deletion of exons 4-22 (Δe4-22).
|
27161151 |
2016 |
Autistic Disorder
|
0.500 |
Biomarker
|
disease |
CTD_human |
Using combined behavioral, electrophysiological, biochemical, imaging, and molecular approaches, we find that Shank3-deficient mice exhibit autism-like social deficits and repetitive behaviors, as well as the significantly diminished NMDA receptor (NMDAR) synaptic function and synaptic distribution in prefrontal cortex.
|
26027926 |
2015 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Copy-number variants and truncating mutations in SHANK genes were present in ∼1% of patients with ASD: mutations in SHANK1 were rare (0.04%) and present in males with normal IQ and autism; mutations in SHANK2 were present in 0.17% of patients with ASD and mild intellectual disability; mutations in SHANK3 were present in 0.69% of patients with ASD and up to 2.12% of the cases with moderate to profound intellectual disability.
|
25188300 |
2014 |
Autistic Disorder
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
SHANK3 gene mutations associated with autism facilitate ligand binding to the Shank3 ankyrin repeat region.
|
23897824 |
2013 |